SONN
Sonnet BioTherapeutics
SONN
SONN
Delisted
SONN was delisted on the 2nd of December, 2025.
10 hedge funds and large institutions have $550K invested in Sonnet BioTherapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
10
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$459K | |
| 2 | +$402K | |
| 3 | +$36.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.5K |